BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Florentin M, Elisaf MS. Proton pump inhibitor-induced hypomagnesemia: A new challenge. World J Nephrol 2012; 1(6): 151-154 [PMID: 24175253 DOI: 10.5527/wjn.v1.i6.151]
URL: https://www.wjgnet.com/2220-6124/full/v1/i6/151.htm
Number Citing Articles
1
Lisanne M. M. Gommers, Thomas H. A. Ederveen, Jenny Wijst, Caro Overmars-Bos, Guus A. M. Kortman, Jos Boekhorst, René J. M. Bindels, Jeroen H. F. Baaij, Joost G. J. Hoenderop. Low gut microbiota diversity and dietary magnesium intake are associated with the development of PPI‐induced hypomagnesemiaThe FASEB Journal 2019; 33(10): 11235 doi: 10.1096/fj.201900839R
2
Kailin Jiang, Xiaotao Jiang, Yi Wen, Liu Liao, Feng‐bin Liu. Relationship between long‐term use of proton pump inhibitors and risk of gastric cancer: A systematic analysisJournal of Gastroenterology and Hepatology 2019; 34(11): 1898 doi: 10.1111/jgh.14759
3
Charlie T Seto, Patricio Jeraldo, Robert Orenstein, Nicholas Chia, John K DiBaise. Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibilityMicrobiome 2014; 2(1) doi: 10.1186/2049-2618-2-42
4
Natasha Daga, Flavian Joseph. Republished: Denosumab-induced severe hypocalcaemia in a patient with vitamin D deficiencyDrug and Therapeutics Bulletin 2021; 59(9): 139 doi: 10.1136/dtb.2021.234508rep
5
Uwe Gröber. Magnesium and DrugsInternational Journal of Molecular Sciences 2019; 20(9): 2094 doi: 10.3390/ijms20092094
6
Antonio Ponzetto, Natale Figura. Serum magnesium and the prevalence of peripheral artery diseaseAtherosclerosis 2020; 292: 230 doi: 10.1016/j.atherosclerosis.2019.10.020
7
Caitlin Burrell, Li Luo, Marieke Kester Jones, Andrea Lee, Elizabeth Freeman, Copper Aitken-Palmer. HEMATOLOGY AND SERUM BIOCHEMISTRY VALUES OF THE RED PANDA SUBSPECIES (AILURUS FULGENS STYANI)Journal of Zoo and Wildlife Medicine 2018; 49(2): 384 doi: 10.1638/2017-0104.1
8
Ala I. Sharara, Jean M. Chalhoub, Nijmeh Hammoud, Ali H. Harb, Fayez S. Sarkis, Ghassan Hamadeh. Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care CohortClinical Gastroenterology and Hepatology 2016; 14(2): 317 doi: 10.1016/j.cgh.2015.10.012
9
Donald F. Kirby, Soumya Chatterjee. Evaluation and management of gastrointestinal manifestations in sclerodermaCurrent Opinion in Rheumatology 2014; 26(6): 621 doi: 10.1097/BOR.0000000000000117
10
Sofía Linares Amorós, Ramón Guirao Martínez, Andrea Bernabé Casanova, Sahelys Gómez Hernández. Hipomagnesemia grave secundaria a inhibidores de la bomba de protones, dos casos clínicosRevista del Laboratorio Clínico 2017; 10(4): 217 doi: 10.1016/j.labcli.2017.07.003
11
Victoria Bîrluţiu, Codruța Mihaela Luca, Rareș-Mircea Bîrluțiu. Streptococcus agalactiae meningoencephalitis associated with gastroesophageal reflux disease and chronic proton pump inhibitors use, in a 9 month-old infant: a case reportBMC Pediatrics 2018; 18(1) doi: 10.1186/s12887-018-0995-0
12
Isabella D Cooper, Catherine A P Crofts, James J DiNicolantonio, Aseem Malhotra, Bradley Elliott, Yvoni Kyriakidou, Kenneth H Brookler. Relationships between hyperinsulinaemia, magnesium, vitamin D, thrombosis and COVID-19: rationale for clinical managementOpen Heart 2020; 7(2): e001356 doi: 10.1136/openhrt-2020-001356
13
Natasha Daga, Flavian Joseph. Denosumab-induced severe hypocalcaemia in a patient with vitamin D deficiencyBMJ Case Reports 2020; 13(8): e234508 doi: 10.1136/bcr-2020-234508
14
Robert E. Carroll, Enrico Benedetti, Joseph P. Schowalter, Alan L. Buchman. Management and Complications of Short Bowel Syndrome: an Updated ReviewCurrent Gastroenterology Reports 2016; 18(7) doi: 10.1007/s11894-016-0511-3
15
Mee Onn Chai, Adrian Coleman. Hypomagnesaemia secondary to omeprazole in stage 5 CKDJournal of Kidney Care 2016; 1(3): 144 doi: 10.12968/jokc.2016.1.3.144
16
Mark W. Hess, Jeroen H. F. de Baaij, Lisanne M. M. Gommers, Joost G. J. Hoenderop, René J. M. Bindels, Hauke Smidt. Dietary Inulin Fibers Prevent Proton-Pump Inhibitor (PPI)-Induced Hypocalcemia in MicePLOS ONE 2015; 10(9): e0138881 doi: 10.1371/journal.pone.0138881
17
Florence van Hunsel, Laura Peters, Helga Gardarsdottir, Agnes Kant. Assessing the Impact on Health of Pharmacovigilance Activities: Example of Four Safety SignalsDrug Safety 2021; 44(5): 589 doi: 10.1007/s40264-021-01047-1
18
Kristen P Hamilton, Rena Zelig, Anna R Parker, Amina Haggag. Insulin Resistance and Serum Magnesium Concentrations among Women with Polycystic Ovary SyndromeCurrent Developments in Nutrition 2019; 3(11) doi: 10.1093/cdn/nzz108
19
Singh Saraj Kumar, Goel Khushbu, Mukherji Joy Dev. Hypomagnesaemia induced recurrent cerebellar ataxia: an interesting case with successful managementCerebellum & Ataxias 2020; 7(1) doi: 10.1186/s40673-019-0110-9
20
James Wei Tatt Toh, Evonne Ong, Robert Wilson. Hypomagnesaemia associated with long-term use of proton pump inhibitorsGastroenterology Report 2015; 3(3): 243 doi: 10.1093/gastro/gou054
21
Krasimir Kostov. Effects of Magnesium Deficiency on Mechanisms of Insulin Resistance in Type 2 Diabetes: Focusing on the Processes of Insulin Secretion and SignalingInternational Journal of Molecular Sciences 2019; 20(6): 1351 doi: 10.3390/ijms20061351
22
Amandeep Singh, Gail A. Cresci, Donald F. Kirby. Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut MicrobiomeNutrition in Clinical Practice 2018; 33(5): 614 doi: 10.1002/ncp.10181
23
Arun Koyyada. Long-term use of proton pump inhibitors as a risk factor for various adverse manifestationsTherapies 2021; 76(1): 13 doi: 10.1016/j.therap.2020.06.019
24
Kuen Shan Jih, Ming Fu Wang, Ying Ju Chen. COPD Patients with Acute Exacerbation Who Developed Refeeding Syndrome during Hospitalization Had Poor Outcome: A Retrospective Cohort StudyInternational Journal of Gerontology 2018; 12(1): 62 doi: 10.1016/j.ijge.2017.03.004
25
Christopher M. Stark, Cade M. Nylund, Gregory H. Gorman, Brent L. Lechner. Primary renal magnesium wasting: an unusual clinical picture of exercise-induced symptomsPhysiological Reports 2016; 4(8): e12773 doi: 10.14814/phy2.12773
26
Mohamed Saad, Hassan Mitwally. Lansoprazole-Induced Thrombocytopenia in a Critically Ill Patient: A Case ReportJournal of Pharmacy Practice 2020; 33(5): 700 doi: 10.1177/0897190019838681
27
George Liamis, Ewout J. Hoorn, Matilda Florentin, Haralampos Milionis. An overview of diagnosis and management of drug‐induced hypomagnesemiaPharmacology Research & Perspectives 2021; 9(4) doi: 10.1002/prp2.829
28
Edoardo Savarino, Elisa Marabotto, Patrizia Zentilin, Manuele Furnari, Giorgia Bodini, Gaia Pellegatta, Greta Lorenzon, Marco Della Coletta, Matteo Ghisa, Claudia Coppo, Carla Marinelli, Vincenzo Savarino. A safety review of proton pump inhibitors to treat acid-related digestive diseasesExpert Opinion on Drug Safety 2018; 17(8): 785 doi: 10.1080/14740338.2018.1497155
29
Uwe Gröber, Joachim Schmidt, Klaus Kisters. Important drug-micronutrient interactions: A selection for clinical practiceCritical Reviews in Food Science and Nutrition 2020; 60(2): 257 doi: 10.1080/10408398.2018.1522613
30
Stephanie Urwin, Jamie Willows, John A. Sayer. The challenges of diagnosis and management of Gitelman syndromeClinical Endocrinology 2020; 92(1): 3 doi: 10.1111/cen.14104